nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—CYP2D6—Miscellaneous substrates—CYP4F22—spinal cancer	0.103	0.103	CbGpPWpGaD
Rabeprazole—CYP2D6—Fatty acids—CYP4F22—spinal cancer	0.086	0.086	CbGpPWpGaD
Rabeprazole—CYP1A1—Arachidonic acid metabolism—CYP4F22—spinal cancer	0.0436	0.0436	CbGpPWpGaD
Rabeprazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP4F22—spinal cancer	0.0377	0.0377	CbGpPWpGaD
Rabeprazole—CYP1A1—Oxidation by Cytochrome P450—CYP4F22—spinal cancer	0.0372	0.0372	CbGpPWpGaD
Rabeprazole—CYP2C19—Arachidonic acid metabolism—CYP4F22—spinal cancer	0.0357	0.0357	CbGpPWpGaD
Rabeprazole—CYP2C9—Arachidonic acid metabolism—CYP4F22—spinal cancer	0.0325	0.0325	CbGpPWpGaD
Rabeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP4F22—spinal cancer	0.0308	0.0308	CbGpPWpGaD
Rabeprazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP4F22—spinal cancer	0.0305	0.0305	CbGpPWpGaD
Rabeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP4F22—spinal cancer	0.0304	0.0304	CbGpPWpGaD
Rabeprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP4F22—spinal cancer	0.0284	0.0284	CbGpPWpGaD
Rabeprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP4F22—spinal cancer	0.0281	0.0281	CbGpPWpGaD
Rabeprazole—CYP2D6—Oxidation by Cytochrome P450—CYP4F22—spinal cancer	0.028	0.028	CbGpPWpGaD
Rabeprazole—CYP1A2—Arachidonic acid metabolism—CYP4F22—spinal cancer	0.0278	0.0278	CbGpPWpGaD
Rabeprazole—CYP2C9—Oxidation by Cytochrome P450—CYP4F22—spinal cancer	0.0277	0.0277	CbGpPWpGaD
Rabeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP4F22—spinal cancer	0.025	0.025	CbGpPWpGaD
Rabeprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP4F22—spinal cancer	0.024	0.024	CbGpPWpGaD
Rabeprazole—CYP1A2—Oxidation by Cytochrome P450—CYP4F22—spinal cancer	0.0237	0.0237	CbGpPWpGaD
Rabeprazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP4F22—spinal cancer	0.023	0.023	CbGpPWpGaD
Rabeprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP4F22—spinal cancer	0.0228	0.0228	CbGpPWpGaD
Rabeprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP4F22—spinal cancer	0.0195	0.0195	CbGpPWpGaD
Rabeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4F22—spinal cancer	0.0185	0.0185	CbGpPWpGaD
Rabeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP4F22—spinal cancer	0.0183	0.0183	CbGpPWpGaD
Rabeprazole—CYP1A1—Biological oxidations—CYP4F22—spinal cancer	0.0162	0.0162	CbGpPWpGaD
Rabeprazole—CYP1A1—Metapathway biotransformation—CYP4F22—spinal cancer	0.016	0.016	CbGpPWpGaD
Rabeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP4F22—spinal cancer	0.015	0.015	CbGpPWpGaD
Rabeprazole—CYP2C19—Biological oxidations—CYP4F22—spinal cancer	0.0133	0.0133	CbGpPWpGaD
Rabeprazole—CYP2C19—Metapathway biotransformation—CYP4F22—spinal cancer	0.0131	0.0131	CbGpPWpGaD
Rabeprazole—CYP2D6—Biological oxidations—CYP4F22—spinal cancer	0.0122	0.0122	CbGpPWpGaD
Rabeprazole—CYP2C9—Biological oxidations—CYP4F22—spinal cancer	0.0121	0.0121	CbGpPWpGaD
Rabeprazole—CYP2D6—Metapathway biotransformation—CYP4F22—spinal cancer	0.012	0.012	CbGpPWpGaD
Rabeprazole—CYP2C9—Metapathway biotransformation—CYP4F22—spinal cancer	0.0119	0.0119	CbGpPWpGaD
Rabeprazole—CYP1A2—Biological oxidations—CYP4F22—spinal cancer	0.0103	0.0103	CbGpPWpGaD
Rabeprazole—CYP1A2—Metapathway biotransformation—CYP4F22—spinal cancer	0.0102	0.0102	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—CYP4F22—spinal cancer	0.00798	0.00798	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—CYP4F22—spinal cancer	0.00787	0.00787	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP4F22—spinal cancer	0.00623	0.00623	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—MRI1—spinal cancer	0.00582	0.00582	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP4F22—spinal cancer	0.0051	0.0051	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP4F22—spinal cancer	0.00465	0.00465	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP4F22—spinal cancer	0.0041	0.0041	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP4F22—spinal cancer	0.00397	0.00397	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—MRI1—spinal cancer	0.00394	0.00394	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—MRI1—spinal cancer	0.00322	0.00322	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—MRI1—spinal cancer	0.00296	0.00296	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—MRI1—spinal cancer	0.00294	0.00294	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP4F22—spinal cancer	0.00277	0.00277	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—MRI1—spinal cancer	0.00251	0.00251	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP4F22—spinal cancer	0.00227	0.00227	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP4F22—spinal cancer	0.00209	0.00209	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP4F22—spinal cancer	0.00207	0.00207	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—MRI1—spinal cancer	0.00194	0.00194	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP4F22—spinal cancer	0.00177	0.00177	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP4F22—spinal cancer	0.00137	0.00137	CbGpPWpGaD
